特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
967329

新型コロナウイルス感染症(COVID-19)による遠隔医療への影響、医師の視点

Coronavirus Disease 2019 (COVID-19) Impact on Telemedicine, a Physician Perspective

出版日: | 発行: GlobalData | ページ情報: 英文 51 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=104.89円
新型コロナウイルス感染症(COVID-19)による遠隔医療への影響、医師の視点
出版日: 2020年10月19日
発行: GlobalData
ページ情報: 英文 51 Pages
納期: 即納可能 即納可能とは
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

COVID-19は、患者、ヘルスケアシステム、および支払者によってテクノロジーの可能性がますます実現されるため、遠隔医療の転換点になる可能性があると広く予想されています。パンデミックの結果として、遠隔医療の償還と使用を管理する規制と政策が大幅に変更され、これらのサービスへのアクセスの拡大と前例のない需要につながりました。

当レポートは、新型コロナウイルス感染症(COVID-19)による遠隔医療への影響を調査しており、遠隔医療の利点と障壁、COVID-19パンデミック前・中・後の米国・欧州(フランス、ドイツ、イタリア、スペイン、英国)・日本別の遠隔医療の分析、遠隔医療の今後の見通しなどの情報を提供しています。

目次

目次

  • 遠隔医療の概要
  • 遠隔医療とは?
  • 遠隔医療のタイプとは?
  • 遠隔医療の利点とは?
  • 遠隔医療に対する一般的な障壁とは?
  • COVID-19以前の米国、欧州、および日本の遠隔医療セクター
  • 米国
  • 欧州
  • 日本
  • COVID-19以前の遠隔医療セクター:調査データ
  • COVID-19以前の遠隔医療セクター:地域別の調査データ
  • COVID-19期間中の米国、欧州、および日本の遠隔医療セクター
  • 社会的距離と封鎖措置による遠隔医療利用の急増
  • パンデミックによる米国の遠隔医療の規制状況の変化
  • 一部の欧州諸国における償還方針の変更による遠隔医療の需要急増
  • 日本における遠隔医療の制限を緩和するための新しい措置の導入
  • COVID-19中の遠隔医療セクター:調査データ
  • COVID-19中の遠隔医療セクター:地域別の調査データ
  • COVID-19後の遠隔医療セクター
  • COVID-19後の遠隔医療の未来
  • COVID-19後の遠隔医療セクター:調査データ
  • 要点

付録

  • 調査手法
  • 略語
  • 参考文献
  • 関連レポート
  • 著者について
  • GlobalDataについて
目次
Product Code: GDHCHT203

Telemedicine is the use of electronic communication for the delivery of remote clinical care. It has been recognized as a critical strategy during the ongoing coronavirus disease 2019 (COVID-19) pandemic to limit the risk of person-to-person transmission of the virus as social distancing has become the norm. It is widely anticipated that COVID-19 may be the tipping point for telemedicine as the full potential of the technology is increasingly realized by patients, healthcare systems, and payers. As a result of the pandemic, regulations and policies governing reimbursement and use of telemedicine have changed significantly, leading to expanded access and an unprecedented demand for these services. This case study assesses physician perceptions on telemedicine usage before and during the COVID-19 outbreak in the US, 5EU (France, Germany, Italy, Spain, and the UK), and Japan, as well as expected use of telemedicine post-COVID-19. The case study combines information obtained from secondary sources and primary research with specialists and physicians from different therapy areas (oncology, pulmonology, gastroenterology, cardiology, and infectious disease).

Key Highlights

  • The adoption of telemedicine had been increasing before the COVID-19 crisis, but the uptake was still low: Physicians from the European Union (EU) were leading users of telemedicine solutions pre-COVID-19 (72%), which can be attributed to the EU's attempts to enhance the digitization of its healthcare sectors from 2018. In line with the regulatory landscape, Japanese respondents reported the lowest levels of telemedicine usage pre-COVID-19 (42%). Until 2015, the Japanese Ministry of Health, Labour and Welfare (MHLW) had restricted the use of telemedicine solutions except for patients with chronic diseases in remote areas in the country.
  • Use of telemedicine gained momentum during the COVID-19 pandemic when social distancing became the norm: Telemedicine has been recognized as a critical strategy during the COVID-19 emergency to limit the risk of person-to-person transmission, in turn triggering policymakers in many countries to relax regulations to facilitate widespread usage and adoption of telemedicine. Despite easing of restrictions in Japan, over 50% of respondents reported their use of telemedicine had remained unchanged as a result of the COVID-19 pandemic, whereas in the US and EU, over 75% of respondents increased use of the technology.
  • Telemedicine has the potential to significantly improve delivery of healthcare post-COVID-19: Telemedicine has a potential to address ongoing issues faced by healthcare systems worldwide. These include workforce shortages, an aging society, accessing affordable care, and increased healthcare spending. While only 47% of US physicians were using telemedicine pre-COVID-19, 76% were positive that their usage would continue after the crisis ended. This may suggest that at the time of survey fielding, physicians were optimistic about temporary telemedicine flexibilities being made permanent in the US.

Scope

This case study contains the following -

  • An overview of telemedicine, including benefits and barriers
  • A review of the telemedicine sector in the US, Europe, and Japan before the pandemic, including poll data
  • A review of the telemedicine sector in the US, Europe, and Japan during the pandemic, including poll data
  • A review of the telemedicine sector post COVID-19, including poll data

Reasons to Buy

  • Get an overview of the changing telemedicine regulatory landscapes in the US, Europe, and Japan.
  • See how physician use of telemedicine has changed in these regions as a result of the pandemic.
  • See how physician use of telemedicine is expected to change in the future in these regions.

Table of Contents

Table of Contents

  • Telemedicine Overview
  • What Is Telemedicine?
  • What Are the Different Types of Telemedicine?
  • What Are the Benefits of Telemedicine?
  • What Are the Common Barriers to Telemedicine?
  • Telemedicine Sector in the US, Europe, and Japan Before COVID-19
  • In the US, Pre-Pandemic Use of Telemedicine Was Rising But Remained Low Overall
  • In Europe, the UK Was the Most Established 5EU Market for Telemedicine Before COVID-19
  • Use of Telemedicine Is Still at the Infancy Stage in Japan
  • Telemedicine Sector Before COVID-19 - Survey Data
  • Telemedicine Sector Before COVID-19 - Survey Data by Region
  • Telemedicine Sector in the US, Europe, and Japan During COVID-19
  • Social Distancing and Lockdown Measures Have Led to a Surge in Telemedicine Use
  • The Regulatory Landscape for Telemedicine in the US Has Changed Significantly as a Result of the Pandemic
  • Changes to Reimbursement Policies in Some European Countries Have Led to a Surge in Demand for Telemedicine
  • Japan Has Introduced New Measures to Ease Telemedicine Restrictions
  • Telemedicine Sector During COVID-19 - Survey Data
  • Telemedicine Sector During COVID-19 - Survey Data by Region
  • Telemedicine Sector Post-COVID-19
  • The Future of Telemedicine Post-COVID-19
  • Telemedicine Sector Post-COVID-19 - Survey Data
  • Key Takeaways

Appendix

  • Methodology
  • Abbreviations
  • Bibliography
  • Related Reports
  • About the Authors
  • About GlobalData
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.